131 related articles for article (PubMed ID: 12831635)
1. [Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes].
Mianowska B; Perenc M; Heinrich A; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):29-34. PubMed ID: 12831635
[TBL] [Abstract][Full Text] [Related]
2. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
[TBL] [Abstract][Full Text] [Related]
3. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
4. No relationship between insulin antibodies and hypoglycemia in insulin-treated diabetic patients.
Ionescu-Tîrgovişte C; Mirodon Z; Paterache E; Cheţa D; Mincu I
Rom J Intern Med; 1991; 29(3-4):189-98. PubMed ID: 1784948
[TBL] [Abstract][Full Text] [Related]
5. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
Alemzadeh R; Berhe T; Wyatt DT
Pediatrics; 2005 May; 115(5):1320-4. PubMed ID: 15867042
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of different brands of human insulin and rapid-acting insulin analogs in insulin-naïve children with type 1 diabetes.
Mianowska B; Szadkowska A; Pietrzak I; Zmysłowska A; Wegner O; Tomczonek J; Bodalski J; Młynarski W
Pediatr Diabetes; 2011 Mar; 12(2):78-84. PubMed ID: 20522172
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of anti-insulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients.
Wredling R; Lins PE; Adamson U
Scand J Clin Lab Invest; 1990 Sep; 50(5):551-7. PubMed ID: 2237267
[TBL] [Abstract][Full Text] [Related]
8. [Severe hypoglycemia in children and adolescents suffering from type 1 diabetes mellitus].
Cosmescu A; Felea D; Mătăsaru S
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):955-8. PubMed ID: 20209769
[TBL] [Abstract][Full Text] [Related]
9. Detection of insulin antibodies by radioassay and ELISA: interrelation and correlation with metabolic control in type I diabetes.
Dib SA; Freire MB; Miranda WL; Russo EM
Braz J Med Biol Res; 1994 May; 27(5):1167-80. PubMed ID: 8000338
[TBL] [Abstract][Full Text] [Related]
10. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children.
Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M
Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647
[TBL] [Abstract][Full Text] [Related]
11. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report.
Lahtela JT; Knip M; Paul R; Antonen J; Salmi J
Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.
García L; Lamas C; Tuset MJ; Alonso M; Barrio R
Diabetes Nutr Metab; 2002 Feb; 15(1):7-13. PubMed ID: 11942742
[TBL] [Abstract][Full Text] [Related]
13. Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors.
Limbert C; Schwingshandl J; Haas J; Roth R; Borkenstein M
J Diabetes Complications; 1993; 7(4):216-20. PubMed ID: 8219364
[TBL] [Abstract][Full Text] [Related]
14. Episodes of severe hypoglycemia is associated with a progressive increase in hemoglobin A1c in children and adolescents with type 1 diabetes.
Pilgaard KA; Breinegaard N; Johannesen J; Pörksen S; Fredheim S; Madsen M; Kristensen K; Svensson J; Birkebaek NH
Pediatr Diabetes; 2020 Aug; 21(5):808-813. PubMed ID: 32304129
[TBL] [Abstract][Full Text] [Related]
15. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
Ratner RE; Hirsch IB; Neifing JL; Garg SK; Mecca TE; Wilson CA
Diabetes Care; 2000 May; 23(5):639-43. PubMed ID: 10834423
[TBL] [Abstract][Full Text] [Related]
16. Severe hypoglycaemia in children and adolescents during multiple-dose insulin therapy.
Tupola S; Rajantie J; Mäenpää J
Diabet Med; 1998 Aug; 15(8):695-9. PubMed ID: 9702475
[TBL] [Abstract][Full Text] [Related]
17. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.
Murphy NP; Keane SM; Ong KK; Ford-Adams M; Edge JA; Acerini CL; Dunger DB
Diabetes Care; 2003 Mar; 26(3):799-804. PubMed ID: 12610040
[TBL] [Abstract][Full Text] [Related]
18. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
[TBL] [Abstract][Full Text] [Related]
19. Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes.
Home P; Derwahl KM; Ziemen M; Wernicke-Panten K; Pierre S; Kirchhein Y; Garg SK
Diabetes Technol Ther; 2018 Feb; 20(2):160-170. PubMed ID: 29355435
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies.
Ishizuka T; Ogawa S; Mori T; Nako K; Nakamichi T; Oka Y; Ito S
Diabetes Res Clin Pract; 2009 May; 84(2):e21-3. PubMed ID: 19328577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
